Home Neoplasma 2013 Neoplasma Vol.60, No.5, p.511-515, 2013

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.


Neoplasma Vol.60, No.5, p.511-515, 2013

Title: MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration
Author: H. LI, J. ZHAO, J. W. ZHANG, Q. Y. HUANG, J. Z. HUANG, L. S. CHI, H. J. TANG, G. Q. LIU, D. J. ZHU, W. M. MA

Abstract: Aberrantly expressed microRNAs (miRNAs) are frequently correlated with a  variety of human cancers, including clear cell renal cell carcinoma (ccRCC). In this study, we determined the expression patterns of miR-217 in ccRCC, and tested its effect on cancer cell proliferation and migration. The expression levels of miR-217 were determined in 54 ccRCC samples using Real-Time qPCR. 786-O and ACHN cells were transfected with miR-217 mimics or miRNA mimics control. Cell proliferation and migration were evaluated by MTT assay and scratch-wound assay, respectively. We found that miR-217 was down-regulated in ccRCC compared to paired normal tissue. Lower miR-217 expression levels were associated with higher tumor grade and stage. All patients with high miR-217 expression survived 5 years, while with low miR-217 expression, only 40% survived. Cell proliferation inhibition and decreased motility were observed in cells transfected with the miR-217 mimics. In conclusion, miR-217 plays a  tumor suppressor role in ccRCC.

Keywords: miR-217, clear cell renal cell carcinoma, survival, proliferation, migration
Published online: 24-Jun-2013
Year: 2013, Volume: 60, Issue: 5 Page From: 511, Page To: 515
doi:10.4149/neo_2013_066


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy